Laboratory Corporation of America Holdings
Laboratory Corporation of America Holdings was paid $408K by Medicaid between Jan 2018 and Jul 2024, across 27 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 53% of everything it billed.
CARMEL, IN 46032
Next to other Clinical Medical Laboratory providers in Indiana
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 843 | $6K | |
| 2019 | 1,379 | $8K | |
| 2020 | 2,797 | $78K | |
| 2021 | 7,188 | $182K | |
| 2022 | 7,416 | $48K | |
| 2023 | 8,833 | $62K | |
| 2024incomplete | 3,441 | $24K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 53% | 2,212 | 2,164 | $215K |
| 85060 | 20% | 9,748 | 8,787 | $82K | |
| 80053 | Comprehensive metabolic panel | 3.7% | 2,505 | 2,288 | $15K |
| 82728 | 3.5% | 2,097 | 1,913 | $14K | |
| 82607 | 2.8% | 1,504 | 1,362 | $12K | |
| 84443 | Thyroid stimulating hormone (TSH) | 2.4% | 1,092 | 1,009 | $10K |
| 83550 | 2.4% | 1,894 | 1,717 | $10K | |
| 82746 | 2.3% | 1,303 | 1,182 | $9K | |
| 83540 | 2.0% | 2,127 | 1,933 | $8K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.2% | 424 | 398 | $5K |
| 80061 | Lipid panel | <1% | 680 | 639 | $4K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 112 | 105 | $3K |
15 more codes
| 88141 | <1% | 801 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 639 | $3K |
| 86140 | <1% | 888 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,272 | $3K |
| 85045 | <1% | 1,093 | $3K | |
| 86038 | <1% | 335 | $3K | |
| 83615 | <1% | 382 | $2K | |
| 85652 | <1% | 623 | $1K | |
| 84165 | <1% | 27 | $179.49 | |
| 86803 | <1% | 15 | $134.23 | |
| 83020 | <1% | 12 | $104.90 | |
| 81001 | <1% | 43 | $86.40 | |
| 85730 | <1% | 27 | $82.64 | |
| G0124 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | <1% | 15 | $79.46 |
| 85610 | <1% | 27 | $67.98 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.